share_log

Insiders At Johnson & Johnson Sold US$5.6m In Stock, Alluding To Potential Weakness

Insiders At Johnson & Johnson Sold US$5.6m In Stock, Alluding To Potential Weakness

强生内部人士出售了560万美元的股票,暗示潜在的疲软
Simply Wall St ·  2023/12/26 06:38

Over the past year, many Johnson & Johnson (NYSE:JNJ) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.

在过去的一年中,许多强生(纽约证券交易所代码:JNJ)内部人士出售了该公司的大量股份,这可能激起了投资者的兴趣。在分析内幕交易时,了解内部人士是否在买入通常比知道他们是否在卖出更有价值,因为后者发出的信息模棱两可。但是,股东应更深入地研究是否有几位内部人士在特定时间段内出售股票。

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

尽管在长期投资方面,内幕交易并不是最重要的事情,但我们确实认为密切关注内部人士的所作所为是完全合乎逻辑的。

See our latest analysis for Johnson & Johnson

查看我们对强生公司的最新分析

Johnson & Johnson Insider Transactions Over The Last Year

强生过去一年的内幕交易

In the last twelve months, the biggest single sale by an insider was when the Executive VP & Chief Human Resources Officer, Peter Fasolo, sold US$3.4m worth of shares at a price of US$170 per share. So we know that an insider sold shares at around the present share price of US$155. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

在过去的十二个月中,内部人士最大的一次出售是执行副总裁兼首席人力资源官彼得·法索洛以每股170美元的价格出售了价值340万美元的股票。因此,我们知道一位内部人士以目前的155美元左右的股价出售了股票。虽然我们通常不喜欢看到内幕抛售,但更令人担忧的是销售是否以较低的价格进行。鉴于此次销售以当前价格进行,这使我们有些谨慎,但并不是什么大问题。

Johnson & Johnson insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

强生内部人士去年没有购买任何股票。下图显示了去年的内幕交易(公司和个人)。如果你点击图表,你可以看到所有的个人交易,包括股价、个人和日期!

insider-trading-volume
NYSE:JNJ Insider Trading Volume December 26th 2023
纽约证券交易所:JNJ 内幕交易量 2023 年 12 月 26 日

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一样,那么你不会想错过这份业内人士正在收购的成长型公司的免费名单。

Does Johnson & Johnson Boast High Insider Ownership?

强生公司是否拥有很高的内幕所有权?

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. It's great to see that Johnson & Johnson insiders own 0.07% of the company, worth about US$268m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

查看公司的内部人持股总额可以帮助您了解他们是否与普通股股东保持良好关系。较高的内部人所有权通常会使公司领导层更加关注股东的利益。很高兴看到强生内部人士拥有该公司0.07%的股份,价值约2.68亿美元。内部人士持有这种重大所有权通常会增加公司为所有股东的利益而经营的机会。

So What Do The Johnson & Johnson Insider Transactions Indicate?

那么,强生内部交易表明了什么?

It doesn't really mean much that no insider has traded Johnson & Johnson shares in the last quarter. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the Johnson & Johnson insiders selling. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Johnson & Johnson. You'd be interested to know, that we found 2 warning signs for Johnson & Johnson and we suggest you have a look.

上个季度没有内部人士交易过强生的股票,这并不意味着什么。很高兴看到内幕所有权居高不下,但回顾去年,强生内部人士的抛售并未获得信心。除了了解正在进行的内幕交易外,确定强生面临的风险也是有益的。你可能会感兴趣地知道,我们为强生找到了两个警告信号,我们建议你看看。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

当然,通过寻找其他地方,你可能会找到一笔不错的投资。因此,来看看这份有趣的公司的免费清单吧。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是那些向相关监管机构报告交易的个人。目前,我们仅对公开市场交易和直接利益的私人处置进行核算,但不考虑衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发